Investor Relations

Latest News

Introducing RESONIC™

Soliton, Inc. Rolls Out Its Rapid Acoustic Pulse™ Technology with a Multi-Platform...

Company Overview

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos and temporarily improve the appearance of cellulite. The Company is based in Houston, Texas, and is actively engaged in bringing Rapid Acoustic Pulse (“RAP”) device to the market. The Company believes the technology will offer patients the ability to improve the appearance of their cellulite in a single non-invasive treatment with minimal discomfort and no downtime. The Soliton method for tattoos cannot only dramatically accelerate tattoo removal, but also has the potential to lower removal cost for patients, while increasing profitability to practitioners, and to reduce the potential for unwanted side effects from current laser removal methods.

Stock Information

Industry Classifications


Medical Devices

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

Electromedical And Electrotherapeutic Apparatus (3845)


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Soliton, Inc.
5304 Ashbrook Dr.
Houston, TX 77081
T: 844-705-4866

Investor Relations

T: 832-371-6687

Transfer Agent

T: 800-736-3001